Thor Medical ASA (OL:TRMED) — Market Cap & Net Worth
Market Cap & Net Worth: Thor Medical ASA (TRMED)
Thor Medical ASA (OL:TRMED) has a market capitalization of $168.11 Million (Nkr1.60 Billion) as of May 27, 2026. Listed on the OL stock exchange, this Norway-based company holds position #17341 globally and #143 in its home market, demonstrating a 1.81% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Thor Medical ASA's stock price Nkr4.51 by its total outstanding shares 354220633 (354.22 Million). Analyse Thor Medical ASA (TRMED) cash conversion ratio to see how efficiently the company converts income to cash.
Thor Medical ASA Market Cap History: 2015 to 2026
Thor Medical ASA's market capitalization history from 2015 to 2026. Data shows change from $513.53 Million to $168.11 Million (-8.83% CAGR).
Thor Medical ASA Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Thor Medical ASA's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of TRMED by Market Capitalization
Companies near Thor Medical ASA in the global market cap rankings as of May 27, 2026.
Key companies related to Thor Medical ASA by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #222 globally with a market cap of $110.45 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #418 globally with a market cap of $65.38 Billion USD.
- argenx NV ADR (NASDAQ:ARGX): Ranked #582 globally with a market cap of $45.97 Billion USD.
- UCB S.A. UNSP.ADR 1/2 (F:UNC0): Ranked #606 globally with a market cap of $44.84 Billion USD ( €38.35 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #222 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $110.45 Billion | $435.93 |
| #418 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $65.38 Billion | $634.62 |
| #582 | argenx NV ADR | NASDAQ:ARGX | $45.97 Billion | $787.95 |
| #606 | UCB S.A. UNSP.ADR 1/2 | F:UNC0 | $44.84 Billion | €120.00 |
Thor Medical ASA Historical Marketcap From 2015 to 2026
Between 2015 and today, Thor Medical ASA's market cap moved from $513.53 Million to $ 168.11 Million, with a yearly change of -8.83%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Nkr168.11 Million | -14.10% |
| 2025 | Nkr195.69 Million | +99.62% |
| 2024 | Nkr98.03 Million | +103.88% |
| 2023 | Nkr48.08 Million | +9.88% |
| 2022 | Nkr43.76 Million | -94.84% |
| 2021 | Nkr847.71 Million | +47.77% |
| 2020 | Nkr573.65 Million | -50.50% |
| 2019 | Nkr1.16 Billion | -37.60% |
| 2018 | Nkr1.86 Billion | -37.04% |
| 2017 | Nkr2.95 Billion | -16.28% |
| 2016 | Nkr3.52 Billion | +586.17% |
| 2015 | Nkr513.53 Million | -- |
End of Day Market Cap According to Different Sources
On May 27th, 2026 the market cap of Thor Medical ASA was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $168.11 Million USD |
| MoneyControl | $168.11 Million USD |
| MarketWatch | $168.11 Million USD |
| marketcap.company | $168.11 Million USD |
| Reuters | $168.11 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Thor Medical ASA
Thor Medical ASA produces and supplies alpha-particle emitters for cancer therapy in Norway. It develops Ra224, an isotope of radium; Pb-212, a radioactive isotope of lead; and Th-228, a radioactive isotope of thorium. The company was incorporated in 2009 and is headquartered in Oslo, Norway.